Skip to content

Effect of Dexamethasone as Analgesic Treatment After Total Knee Arthroplasty

Effect of Dexamethasone as Analgesic Treatment After Total Knee Arthroplasty: Subgroup Analyses of The DEX-2-TKA Randomized Clinical Trial

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05008367
Enrollment
485
Registered
2021-08-17
Start date
2018-09-14
Completion date
2020-06-07
Last updated
2021-09-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Pain

Brief summary

Effect of Dexamethasone as Analgesic Treatment After Total Knee Arthroplasty: Subgroup Analyses of The DEX-2-TKA Randomized Clinical Trial This explorative post-hoc analysis is a substudy of the DEX-2-TKA-trial (NCT03506789) investigating diffefferent subgroups of the patients included in the main trial.

Detailed description

Effect of Dexamethasone as Analgesic Treatment After Total Knee Arthroplasty: Subgroup Analyses of The DEX-2-TKA Randomized Clinical Trial This explorative post-hoc analysis is a substudy of the DEX-2-TKA-trial (NCT03506789) investigating diffefferent subgroups of the patients included in the main trial.

Interventions

DRUGDexamethasone

24 mg intravenous Dexamethasone (6 ml)

DRUGIsotonic saline

6 ml of isotonic saline

Sponsors

Copenhagen Trial Unit, Center for Clinical Intervention Research
CollaboratorOTHER
Naestved Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Participation in the DEX-2-TKA-trial

Design outcomes

Primary

MeasureTime frameDescription
Cumulative usage of morphine 0-48 hours postoperativelyTime Frame: 0-48 hours postoperativelyMorphine administered both as patient-controlled analgesia (PCA) i.v. morphine 0-24 hours and oral morphine on demand 24-48 hours, and any other supplemental morphine administered postoperatively. Consumption in mg

Other

MeasureTime frameDescription
Subgroup analysis on heterogeneity in intervention effect of sexTime Frame: 0-48 hours postoperativelySex: male vs. female
Subgroup analysis on heterogeneity in intervention effect of ASA groupTime Frame: 0-48 hours postoperativelyASA group classification: I+II vs. III
Subgroup analysis on heterogeneity in intervention effect of preoperative pain at restTime Frame: 0-48 hours postoperativelyVAS (mm): \> 30 vs. ≤ 30
Subgroup analysis on heterogeneity in intervention effect of ageTime Frame: 0-48 hours postoperativelyAge (years): \> 65 vs. ≤ 65
Subgroup analysis on heterogeneity in intervention effect of type of anesthesiaTime Frame: 0-48 hours postoperativelyType of anesthesia: spinal vs. general Anesthesia+Converted to general anesthesia
Subgroup analysis on heterogeneity in intervention effect of prior daily use (last month) of analgesic medicationTime Frame: 0-48 hours postoperativelyPrior daily use of paracetamol or NSAID: either parecetamol or NSAID vs. neither parecetamol or NSAID
Subgroup analysis on heterogeneity in intervention effect of preoperative pain when activeTime Frame: 0-48 hours postoperativelyVAS (mm): \> 30 vs. ≤ 30

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026